Twelve major U.S. health systems serving nearly 20 million patients annually have formed the Diagnostic AI Consortium with Aidoc to jointly test and govern diagnostic AI tools, with initial results expected in 2027.
The FDA has scheduled a September 23, 2026 advisory panel review of Grail's Galleri blood test, an AI-driven screen for more than 50 cancer types, despite a UK trial earlier this year that missed its primary endpoint.
UnitedHealth CEO Stephen Hemsley faced tough questions from Rep. Robin Kelly over AI-driven claim denial rates reportedly 16 times higher than typical, as Cigna and UnitedHealth both face active lawsuits over algorithmic claims processing.
A new Chalmers University AI model dramatically speeds up molecular dynamics simulations central to drug discovery, part of a broader 2026 push by pharma companies to pool structural data and train shared AI models like OpenFold3.
A device-agnostic AI platform unveiled at THT 2026 in Boston converts data from ordinary consumer wearables into early warnings for heart failure patients, reportedly cutting hospitalizations through earlier intervention.
Texas A&M and USC researchers are separately developing AI models that map Alzheimer's disease progression with far more precision than current diagnostics, potentially widening the window for early treatment.
Full results from the Swedish MASAI trial, involving over 105,000 women, show AI-supported mammography screening cut interval breast cancers by 12% and invasive interval cancers by 16% compared with standard double reading.
Apple has scaled back its planned standalone AI health coaching service, opting to roll out features gradually within its free Health app instead, even as rival Google launches a paid AI Health Coach.
A new AI foundation model trained on 1.6 million continuous glucose monitor readings cut one-hour glucose forecasting error nearly in half, promising more reliable diabetes management tools.
The FDA cleared Alife Health's Embryo Predict, the first AI embryo assessment tool for IVF backed by a 440-patient randomized clinical trial across seven U.S. fertility clinics.